3‑Hydroxy-Beta-Lactam Inhibitors of Dihydrofolate Synthetase
Saved in:
| Main Authors: | Brett Virgin-Downey, Luting Fang, Charles R. Nosal, Timothy A. Wencewicz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Bio & Med Chem Au |
| Online Access: | https://doi.org/10.1021/acsbiomedchemau.5c00036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation.
by: Grace Mugumbate, et al.
Published: (2015-01-01) -
Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01) -
Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistance.
by: Anna Turkiewicz, et al.
Published: (2020-12-01) -
Molecular modeling, synthesis and biological evaluation of caffeic acid based Dihydrofolate reductase inhibitors
by: Renu Sehrawat, et al.
Published: (2024-12-01) -
Impact of Extending Beta-Lactam Infusions on IV Access Requirements
by: Kirstin J. Kooda, PharmD, et al.
Published: (2025-08-01)